These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35099012)

  • 21. A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.
    Bredenbeek PJ; Molenkamp R; Spaan WJ; Deubel V; Marianneau P; Salvato MS; Moshkoff D; Zapata J; Tikhonov I; Patterson J; Carrion R; Ticer A; Brasky K; Lukashevich IS
    Virology; 2006 Feb; 345(2):299-304. PubMed ID: 16412488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa Virus.
    Deschambault Y; Soule G; Klassen L; Sloan A; Audet J; Azaransky K; Musa AS; Ahmad A; Akinpelu AM; Mba N; Stein DR; Ranson M; Almiski M; Tierney K; Fischer G; Chan M; Safronetz D
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model.
    Welch SR; Scholte FEM; Albariño CG; Kainulainen MH; Coleman-McCray JD; Guerrero LW; Chakrabarti AK; Klena JD; Nichol ST; Spengler JR; Spiropoulou CF
    Front Cell Infect Microbiol; 2018; 8():240. PubMed ID: 30050872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
    Hashizume M; Takashima A; Iwasaki M
    J Virol; 2024 Jun; 98(6):e0057824. PubMed ID: 38767352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge.
    Fischer RJ; Purushotham JN; van Doremalen N; Sebastian S; Meade-White K; Cordova K; Letko M; Jeremiah Matson M; Feldmann F; Haddock E; LaCasse R; Saturday G; Lambe T; Gilbert SC; Munster VJ
    NPJ Vaccines; 2021 Mar; 6(1):32. PubMed ID: 33654106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates.
    Woolsey C; Cross RW; Prasad AN; Agans KN; Borisevich V; Deer DJ; Dobias NS; Fears AC; Harrison MB; Heinrich ML; Fenton KA; Garry RF; Branco LM; Geisbert TW
    Emerg Microbes Infect; 2024 Dec; 13(1):2301061. PubMed ID: 38164768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever.
    Lan S; Shieh WJ; Huang Q; Zaki SR; Liang Y; Ly H
    Virulence; 2020 Dec; 11(1):1131-1141. PubMed ID: 32799623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation.
    Johnson DM; Cubitt B; Pfeffer TL; de la Torre JC; Lukashevich IS
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33573250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lassa virus antigen distribution and inflammation in the ear of infected strain 13/N Guinea pigs.
    Huynh T; Gary JM; Welch SR; Coleman-McCray J; Harmon JR; Kainulainen MH; Bollweg BC; Ritter JM; Shieh WJ; Nichol ST; Zaki SR; Spiropoulou CF; Spengler JR
    Antiviral Res; 2020 Nov; 183():104928. PubMed ID: 32898586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
    Lukashevich IS; Patterson J; Carrion R; Moshkoff D; Ticer A; Zapata J; Brasky K; Geiger R; Hubbard GB; Bryant J; Salvato MS
    J Virol; 2005 Nov; 79(22):13934-42. PubMed ID: 16254329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hearing loss in outbred Hartley guinea pigs experimentally infected with Pichinde virus as a surrogate model of human mammarenaviral hemorrhagic fevers.
    Brisse M; Fernández-Alarcón C; Huang Q; Kirk N; Schleiss MR; Liang Y; Ly H
    Virulence; 2022 Dec; 13(1):1049-1061. PubMed ID: 35758052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever.
    Abreu-Mota T; Hagen KR; Cooper K; Jahrling PB; Tan G; Wirblich C; Johnson RF; Schnell MJ
    Nat Commun; 2018 Oct; 9(1):4223. PubMed ID: 30310067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates.
    Stein DR; Warner BM; Audet J; Soule G; Siragam V; Sroga P; Griffin BD; Leung A; Grolla A; Tierney K; Albietz A; Kobasa D; Musa AS; Ahmad A; Akinpelu AM; Mba N; Rosenke R; Scott DP; Saturday G; Ihekweazu C; Safronetz D
    PLoS Pathog; 2021 Oct; 17(10):e1009966. PubMed ID: 34634087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development.
    Ibukun FI
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32244402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).
    Liu DX; Perry DL; DeWald LE; Cai Y; Hagen KR; Cooper TK; Huzella LM; Hart R; Bonilla A; Bernbaum JG; Janosko KB; Adams R; Johnson RF; Kuhn JH; Schnell MJ; Crozier I; Jahrling PB; de la Torre JC
    J Infect Dis; 2019 May; 219(11):1818-1822. PubMed ID: 30517671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of Lassa virus infection in guinea pigs.
    Jahrling PB; Smith S; Hesse RA; Rhoderick JB
    Infect Immun; 1982 Aug; 37(2):771-8. PubMed ID: 6749685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Households as hotspots of Lassa fever? Assessing the spatial distribution of Lassa virus-infected rodents in rural villages of Guinea.
    Mariën J; Lo Iacono G; Rieger T; Magassouba N; Günther S; Fichet-Calvet E
    Emerg Microbes Infect; 2020 Dec; 9(1):1055-1064. PubMed ID: 32459576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.
    Jiang X; Dalebout TJ; Bredenbeek PJ; Carrion R; Brasky K; Patterson J; Goicochea M; Bryant J; Salvato MS; Lukashevich IS
    Vaccine; 2011 Feb; 29(6):1248-57. PubMed ID: 21145373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.